Halozyme Announces Janssen Receives European Marketing Authorizations For DARZALEX (daratumumab) Subcutaneous Formulation For Newly Diagnosed Systemic Light-Chain Amyloidosis And Pre-Treated Multiple...

Related Tickers: $JNJ $HALO
Read more at: 